Table 3.
PCR: |
• More expensive than culture |
• May be difficult to perform (requires trained staff) and to implement outside the hospital setting (requires dedicated laboratory space) |
• Sensitivity decreases with increasing cough duration |
• Commercial kits are not widely available |
• Subject to contamination, especially during outbreak situations |
Serology: |
• Testing is mostly done in immunologically nonnaive populations |
• Testing is done with an antigen (pertussis toxin) that is contained in all acellular vaccines |
• Immune response to vaccine antigens cannot be distinguished from response to infection |
• Interpretation of serology depends on vaccination history |
• Population-based cutoffs may need verification after change of vaccination calendar |
• Problems in serodiagnosis of B. parapertussis infections |
Abbreviation: PCR, polymerase chain reaction.